Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medisys rejigs senior team ahead of change in focus

This article was originally published in Clinica

Executive Summary

UK syringe and glucose monitoring unit producer Medisys has elevated chief operating officer David Conn to the position of CEO, ahead of the company's planned transition from a product development business to a diversified medical devices company. His appointment, and two associated changes to the composition of the senior management, are designed to help the company maximise the commercial potential of products that are on the point of launch in the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061950

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel